Oncology

Latest News

Top 5 Most-Read Oncology Content of 2024

December 25th 2024

This year’s most-read oncology content of 2024 includes topics on clinical trials, drug access, vaping and lung cancer, and more!

Most Popular Articles of 2024 in Evidence-Based Oncology

By Mary Caffrey

December 23rd 2024

ICYMI: Highlights From ASCO 2024

By Pearl Steinzor

December 21st 2024

chemotherapy | Image credit: Penn Medicine

The High Cost of Shortages of Low-Cost Chemotherapy

By Interview by Mary Caffrey

December 19th 2024

Leukemia diagnosis | Image credit: Vitalii Vodolazskyi - stock.adobe.com

Real-World Treatment Sequences and Cost Analysis of cBTKis in CLL

By Pearl Steinzor

December 17th 2024

Join this panel as they discuss treatment for metastatic NSCLC patients without driver mutations.

Watch the series now!

Watch Now

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

October 16th 2017

St. Jude Study Questions Efficacy of the Flu Vaccine in Children With Leukemia

Surabhi Dangi-Garimella, PhD

The study found that young patients with leukemia who have been vaccinated against the influenza virus are as susceptible to develop flu as their unvaccinated peers.

October 16th 2017

Pharmacy Team Engagement in Navigating the Revenue Cycle for High-Cost Medications in Patients With Cancer

Brandon R. Shank, PharmD, MPH, BCOP Phuoc Anh (Anne) Nguyen, PharmD, MS, BCPS Emily C. Pherson, PharmD, BCPS

With the clinical and financial implications of high-cost medications, and their impact on health system revenue, it is of utmost importance for all key stakeholders to be engaged in the complex revenue cycle.

October 16th 2017

Patients With Early Small Cell Lung Cancer Respond Favorably to Opdivo, Yervoy Combo

Jaime Rosenberg

The study showed that using tumor mutation burden (TMB) can be beneficial for predicting patient response to the combination of 2 immuno-oncology therapies.

October 13th 2017

Diagnosing and Treating Neutropenia: Q&A With Dr Daniel J. DeAngelo

Before treating certain patients, Daniel J. DeAngelo, MD, JD, of Harvard Medical School and the Dana-Farber Cancer Institute, will council them on the risk of developing neutropenia, which can result in hospitalization or even an intensive care stay.

October 13th 2017

AJMC®tv Interviews, October 2017

The Center for Biosimilars® Laura Joszt, MA

AJMC®TV interviews let you catch up on what’s new and important about changes in healthcare, with insights from key decision makers-from the clinician, to the health plan leader, to the regulator. When every minute in your day matters, AJMC®TV interviews keep you informed. Access the video clips at ajmc.com/interviews.

October 13th 2017

Medical World News®, October 2017

AJMC Staff

An update on the latest developments in the world of oncology care: product approvals, clinical developments, health policy changes, and more.

October 13th 2017

Stand Up To Cancer Awards $5.5 Million for Epigenetic Immunotherapy Trials

Jaime Rosenberg

While many lung and bladder cancer patients respond well to immunotherapy, they eventually succumb to the disease because the immune system can not detect the cancer cells. Two clinical trials will combine immunotherapy with epigenetic agents in order to allow the immune system to recognize and destroy the cancer cells.

October 13th 2017

Pharmacy's Changing Role as Cancer Care Transitions From Infused to Oral Therapies

Stacey McCullough, PharmD Ricky Newton, CPA

The advent of oral oncolytics has changed the pharmacy's role in patient care beyond compounding infusions. Pharmacy staff now routinely engage patients, assessing adherence and tolerance to therapy as well as helping them navigate prescription benefits.

October 11th 2017

Deficient Mismatch Repair Extends Disease-Free Survival in CRC

Jaime Rosenberg

Patients with stage III colon cancer with deficient DNA mismatch repair (MMR) genes who are treated with FOLFOX have a more favorable prognosis than those with proficient MMRs.

October 11th 2017

A Reproductive Endocrinologist Discusses Need to Cover Fertility Intervention in Cancer Care

Surabhi Dangi-Garimella, PhD

The American Journal of Managed CareÂ® spoke with Jane L. Frederick, MD, FACOG, a reproductive endocrinologist and fertility specialist, about the changing landscape of cancer treatment, partnering with oncologists, and helping patients gain financial assistance for their fertility preservation and treatment.

October 10th 2017

Study Shows Most Cases of Liver Cancer Can Be Prevented

Jaime Rosenberg

Study focused on liver cancer cases, over time, in different locations and the main causes.

October 9th 2017

Oncologists Skeptical of Omitting Radiation Therapy in Early-Stage Breast Cancer in Older Women

Surabhi Dangi-Garimella, PhD

A new study highlights how the beliefs of surgeons and radiation oncologists influences radiotherapy use in early-stage breast cancer among older women.

October 9th 2017

Dr Michael Kolodziej on How Technology Will Improve Patient Access to Clinical Trials

Technological advances will lead to improvements in clinical trials and greater participation in trials by patients, explained Michael Kolodziej, MD, national medical director of managed care strategy at Flatiron Health.

October 7th 2017

Podcast: This Week in Managed Care - Finding a New HHS Secretary, and Other Health News

Every week, The American Journal of Managed CareÂ® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

October 6th 2017

CDC Calls Attention to Connections Between Obesity and Cancer

Mary Caffrey

The US Preventive Services Task Force already has recommendations for screening and intervention for obesity, but they often are not followed.

October 6th 2017

This Week in Managed Care: October 6, 2017

This week, the top managed care stories included speculation regarding who would replace Tom Price, MD, as HHS secretary; a report on breast cancer mortality trends and racial disparities from 1989 to 2015; and the FDA announced new strategies to improve patient access to less expensive drugs.

October 6th 2017

European Study Questions Survival, QOL Benefit of Marketed Cancer Drugs

Surabhi Dangi-Garimella, PhD

A new study in the journal BMJ concludes that most oncology drugs approved by the European Medicines Agency between 2009 and 2013 failed to display a benefit on survival or quality of life, even at 3.3 years following market entry.

October 6th 2017

Tesh Khullar: Community Oncologists Have to Be Business Experts to Stay Alive

As the health system evolves it will become increasingly important that practices understand business, explained Tesh Khullar, senior vice president of provider solutions at Flatiron Health.

October 5th 2017

Timing, Sequence Critical for Efficacy of Combination Immunotherapy Treatment

Surabhi Dangi-Garimella, PhD

A research study conducted in a mouse mammary cancer model has found that optimal timing, based on sequencing of immunotherapy agents, is important for treatment efficacy.

October 5th 2017

Survey Quantifies Precision Medicine Awareness Among Health System Leaders

Surabhi Dangi-Garimella, PhD

A new survey conducted by The Health Management Academy has identified a rapid investment by leading healthcare systems in precision medicine programs, with significant expectations of the impact of real-world outcomes on physician decision making.

October 4th 2017

Fas Biomarker Predicts Response to Second-Line Therapy for Advanced Soft Tissue Sarcoma

AJMC Staff

October 4th 2017

Aaron Lyss on Challenges When Transitioning to Value-Based Payments

There are 2 categories of challenges facing oncology practices as they transition to value-based payment models, said Aaron Lyss, director of value-based care for Tennessee Oncology.

October 4th 2017

Drop in Breast Cancer Death Rate Saved More Than 322,000 Lives From 1989 to 2015

Laura Joszt, MA

While death rates from breast cancer declined 39% from 1989 to 2015, there are clear racial differences with black women having higher breast cancer death rates than white women, according to a new report from the American Cancer Society.

October 3rd 2017

ASCO, Friends of Cancer Research Call for More Inclusive Cancer Clinical Trials

Christina Mattina

Clinical trials researching cancer therapies should be more inclusive of a broader range of patients, according to the American Society of Clinical Oncology (ASCO) and Friends of Cancer Research.

October 2nd 2017

Updates to Treatment Options During Breast Cancer Awareness Month

Surabhi Dangi-Garimella, PhD

October is breast cancer awareness month, and as September ended, a new treatment received the FDA’s approval for advanced breast cancer and another was granted priority review for the adjuvant treatment of early breast cancer.

October 2nd 2017

Dan Todd Highlights Policy Changes Community Oncologists Should Look Out For

Drug pricing is one area where there may be potential future policy changes that impact community oncologists, said Dan Todd, JD, principal at Todd Strategy.

October 1st 2017

Study Finds Outreach Interventions Effective for CRC Screenings

Alison Rodriguez

Outreach interventions, including mail outreach invitations, may be effective in increasing the proportion of completed colorectal cancer screening, according to research.

September 30th 2017

Podcast: This Week in Managed Care - Latest ACA Repeal Fails, and Other Health News

Every week, The American Journal of Managed CareÂ® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

September 29th 2017

5 Takeaways for Payers and Providers From the NCCN Meeting on Quality Metrics

Surabhi Dangi-Garimella, PhD

Key lessons learnt at the National Comprehensive Cancer Network's policy meeting: Redefining Quality Measurement in Oncology.

September 29th 2017

Navigating the Quality Landscape in Oncology: Pitfalls and Lessons Learned

Surabhi Dangi-Garimella, PhD

Ensuring access to appropriate data and then using the information to improve healthcare outcomes remains an ongoing challenge-this was the conclusion drawn by panelists participating at the National Comprehensive Cancer Network’s Oncology Policy Summit on Redefining Quality Measurement in Oncology.

...

60 61 62 63 64 65 66 67 68

...

181 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions